-
Mashup Score: 1Dear Mayo Clinic: What is cholangiocarcinoma and how is it treated? - Mayo Clinic Comprehensive Cancer Center Blog - 9 month(s) ago
Dr. Rory Smoot explains what cholangiocarcinoma is and how the rare bile duct cancer is diagnosed and treated.
Categories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 6Clinical trial researching chemotherapy for bile duct cancer - 1 year(s) ago
Cholangiocarcinoma is a cancer of the bile ducts, a network of tubes that connect the liver, gallbladder and small intestine. One way to treat such cancer is to deliver drugs directly to the liver itself. A clinical trial led by Jonathan M. Hernandez, M.D., Investigator in the Surgical Oncology Program, is researching chemotherapy for liver-only cholangiocarcinoma (cancer that has occurred in the…
Source: ccr.cancer.govCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
NOW ENROLLING: An NCI clinical trial is testing chemotherapy for bile duct cancer. There is no cost for participation. Learn more. https://t.co/UJqJSAwIPZ #cholangiocarcinoma #BileDuctCancer @NCIResearchCtr @NCICancerTrials https://t.co/H666SJyEVb
-
-
Mashup Score: 0
By Matthew Stenger Posted: 3/31/2023 10:47:00 AM Last Updated: 3/31/2023 9:57:56 AM In a study reported in a research letter in JAMA Oncology, Konstantinidou et al found that the prevalence of hypercalcemia increased over time in patients with cholangiocarcinoma and was significantly more common in those…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Hypercalcemia in Patients With Cholangiocarcinoma https://t.co/ODYFDzwZZx #hpbcsm #cholangiocarcinoma #bileductcancer #hypercalcemia #oncology
-
-
Mashup Score: 3
Understanding the lifestyle factors that contribute to the onset of biliary tract cancers may ultimately help lower risk.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ICYMI: Research is advancing new treatments for #gallbladdercancer and #bileductcancer. Learn more on the #AACRBlog: https://t.co/QIF2erWeW8 #cholangiocarcinoma https://t.co/V0DT76ME6w
-
-
Mashup Score: 0Oncology Journal Network Highlights - 1 year(s) ago
Oncology Journal Network Highlights
Source: www.elsevier.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Elsevier is a proud supporter of Gallbladder & Bile Duct Cancer Awareness Month. To support this important month, we have selected some popular articles from our Oncology Journal Network #Gallbladdercancer #BileDuctCancer #healthdays2022 View collection: https://t.co/y7F6W4VKv6 https://t.co/CAf01K5vQg
-
-
Mashup Score: 0Targeting tumor microenvironment for cholangiocarcinoma: Opportunities for precision medicine - 1 year(s) ago
Systemic treatments (e.g., chemotherapy and targeted therapies) have limited efficacy for patients with locally advanced – unresectable – and metastat…
Source: www.sciencedirect.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
‘Targeting #TME for cholangiocarcinoma: Opportunities for precision medicine’ by R Carloni, G Brandi, et al. https://t.co/0GiSTCzCkT published in #TranslationalOncology & included in our #gallbladder and #bileductcancer awareness collection: https://t.co/4946OeMaSm https://t.co/tvSGMwVNdp
-
-
Mashup Score: 0
Liver and Intrahepatic Bile Duct Cancer statistics
Source: SEERCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The median age of diagnosis for #LiverCancer and intrahepatic #BileDuctCancer is 66. Most diagnoses happen in people between 55-74 years old. Visit our Cancer Stat Facts sheet to learn more: https://t.co/FrHmaCmCA7 https://t.co/2tHNOioQsC
-
-
Mashup Score: 0Oncology Journal Network Highlights - 1 year(s) ago
Oncology Journal Network Highlights
Source: www.elsevier.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Elsevier is a proud supporter of Gallbladder & Bile Duct Cancer Awareness Month. To support this important month, we have selected some popular articles from our Oncology Journal Network #Gallbladdercancer #BileDuctCancer #healthdays2022 View collection: https://t.co/d41qhhDhve https://t.co/627mMQSoqS
-
-
Mashup Score: 0
Liver and Intrahepatic Bile Duct Cancer statistics
Source: SEERCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
The survival rate for #LiverCancer and #BileDuctCancer is increasing. #CancerPrevention includes avoiding alcohol and tobacco. Visit our Cancer Stat Facts sheet: https://t.co/FrHmaCmCA7 and NCI PDQ: https://t.co/BfNfPKLXPK https://t.co/F8f0eF1ctx
-
-
Mashup Score: 0
Liver and Intrahepatic Bile Duct Cancer statistics
Source: SEERCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Rates of new cases of #LiverCancer and intrahepatic #BileDuctCancer are almost 3x higher for men than women. The rate is highest for Non-Hispanic American Indian/Alaska Natives. Visit our Cancer Stat Facts sheet to learn more: https://t.co/FrHmaCnapF https://t.co/TBtuDf59HP
-
.@MayoCancerCare surgical oncologist Dr. Rory Smoot explains what #cholangiocarcinoma is and how the rare #BileDuctCancer is diagnosed and treated. https://t.co/0FCClRDlaZ @RorySmoot78